Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Former Rusal chief launches London’s first mining SPAC, LanzaTech partners with Northwestern, Yale and NREL to establish new biology center, and Jupiter Wellness initiates clinical trial for new treatment for tinnitus
Former Rusal chief launches London’s first mining SPAC
One of the most prominent Anglo-Russian executives in the metals industry is seeking to raise $125mn for a new mining venture through a London-listed special purpose acquisition company. Artem Volynets, former chief executive of EN+ Group, believes now is a good time for mining deals, particularly for critical metals such as copper and cobalt, despite difficult market conditions.
The new blank-check fund, ACG, is seeking to raise up to $125mn in its initial public offering on Thursday and will identify a target mine producing copper, nickel, cobalt or another metal.
READLanzaTech, Northwestern University, Yale University, and NREL to Establish New Center for Multi-Scale Synthetic Biology
The U.S. Department of Energy (DOE) recently announced $178 million for bioenergy research to advance sustainable technology breakthroughs that can improve public health, address climate change, improve food and agricultural production, and create more resilient supply chains.
A team from Northwestern University, LanzaTech NZ, Inc. (LanzaTech), Yale University, and National Renewable Energy Laboratory (NREL) received $18.5 Million in funding from this grant for integrating cell?free systems and genome engineering to accelerate biosystems design for carbon?negative biomanufacturing.
LanzaTech has entered into a merger agreement for a business combination transaction with AMCI Acquisition Corp. II (Nasdaq: AMCI).
READJupiter Wellness Initiates Clinical Trial for Potential New Treatment for Tinnitus
Jupiter Wellness, Inc. (Nasdaq:JUPW), a wellness company focused on hair loss, eczema, burns, and sexual wellness announced today the initiation of a triple-blinded clinical study evaluating a possible treatment for tinnitus. To date, no effective treatment exists for tinnitus.
READAt the SPAC of Dawn (UPDATED) It was a slow start to the day after the Christmas holiday, especially because the SEC was “experiencing technical difficulties” this morning. That makes for a slow news day. Other than that, we hope everyone had a great holiday and is easing back into the work flow. Deals and...
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...